Literature DB >> 24389570

Differences in reported medical conditions between myogenous and arthrogenous TMD patients and its relevance to the general practitioner.

Gary D Klasser, Jennifer Bassiur, Reny de Leeuw.   

Abstract

OBJECTIVE: The aim of this study was to compare self-reported medical conditions between a group of myogenous and arthrogenous temporomandibular disorder (TMD) patients and highlight its relevance to the general practitioner. METHOD AND MATERIALS: The patient population consisted of 274 consecutive patients (14.6% male, 85.4% female; mean age 39.6 ± 14.2 years) diagnosed with either myogenous or arthrogenous TMD according to the Research Diagnostic Criteria for Temporomandibular Disorders. Self-reported medical conditions were derived from a standardized medical health questionnaire that patients completed during their initial examination. Data were compared between the two groups by means of chi-square tests, t tests and Mann-Whitney U tests. The level of significance was set at α = .05.
RESULTS: Patients with myogenous TMD reported a greater number of medical conditions compared to arthrogenous TMD patients from the following broad categories: neurologic, gastrointestinal, musculoskeletal, psychologic, and "other". The following nine specific conditions were reported significantly more often in the myogenous group: severe headaches, fainting/dizzy spells, gastric acid reflux, fibromyalgia, anxiety, depression, psychiatric treatment, phobias, and frequent sore throats. The myogenous group reported pain to be significantly more severe than the arthrogenous group. Pain duration did not differ between the two groups.
CONCLUSION: Patients with myogenous TMD self-reported significantly more comorbid disorders and more severe pain than patients with arthrogenous TMD. Understanding the differences between these two groups of patients will allow for more appropriate and targeted care for these populations. Future studies may focus on determining subgroups that are more likely to be indicative of a larger widespread pain syndrome to help guide individualized management strategies.

Entities:  

Mesh:

Year:  2014        PMID: 24389570     DOI: 10.3290/j.qi.a30999

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  6 in total

1.  The impact of the COVID-19 pandemic on orofacial pain practice: Perceptions from a convenience sample of orofacial pain practitioners.

Authors:  Fernanda Yanez Regonesi; Ghabi A Kaspo; Ian A Boggero; Isabel Moreno-Hay
Journal:  J Am Dent Assoc       Date:  2022-04-25       Impact factor: 3.454

2.  Comparison of sleep quality deterioration by subgroup of painful temporomandibular disorder based on diagnostic criteria for temporomandibular disorders.

Authors:  Yeon-Hee Lee; Q-Schick Auh
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

3.  Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration.

Authors:  Haissam Dahan; Yoram Shir; Ana Velly; Paul Allison
Journal:  J Headache Pain       Date:  2015-05-20       Impact factor: 7.277

Review 4.  Mental Status as a Common Factor for Masticatory Muscle Pain: A Systematic Review.

Authors:  Mieszko Wieckiewicz; Marek Zietek; Joanna Smardz; Dobrochna Zenczak-Wieckiewicz; Natalia Grychowska
Journal:  Front Psychol       Date:  2017-05-09

5.  Comparison of the Effects of Myotherapy in Patients with Myofascial Pain with and without Self-Reported Sleep Bruxism Using The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I Questionnaire.

Authors:  Małgorzata Gałczyńska-Rusin; Małgorzata Pobudek-Radzikowska; Agata Prylińska-Czyżewska; Zofia Maciejewska-Szaniec; Krzystof Gawriołek; Izabela Strużycka; Agata Czajka-Jakubowska
Journal:  Med Sci Monit       Date:  2021-12-01

6.  Association between temporomandibular disorders, chronic diseases, and ophthalmologic and otolaryngologic disorders in Korean adults: A cross-sectional study.

Authors:  Hyun-Seop Song; Joon-Shik Shin; Jinho Lee; Yoon Jae Lee; Me-Riong Kim; Jae-Heung Cho; Koh-Woon Kim; Yeoncheol Park; Hyun Jin Song; Sun-Young Park; Seoyoun Kim; Mia Kim; In-Hyuk Ha
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.